Viridian Therapeutics (NASDAQ:VRDN) reported its Q2 earnings results on Monday, August 15, 2022 at 07:00 AM.
Here’s what investors need to know about the announcement.
Earnings
Viridian Therapeutics missed estimated earnings by 17.78%, reporting an EPS of $-1.06 versus an estimate of $-0.9.
Revenue was down $834 thousand from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.1 which was followed by a 28.03% increase in the share price the next day.
To track all earnings releases for Viridian Therapeutics visit their earnings calendar here.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
